Lista de obras -

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

artículo científico publicado en 2005

Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG.

artículo científico publicado en 2002

CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.

artículo científico publicado en 2016

Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment

artículo científico publicado en 2007

Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α.

artículo científico publicado en 2013

Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine

artículo científico publicado en 2005

Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in mice

artículo científico publicado en 2002

Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1.

artículo científico publicado en 2005

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype

artículo científico publicado en 2002

Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients

artículo científico publicado en 2006

Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.

artículo científico publicado en 2006

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

artículo científico publicado en 2008

Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity

artículo científico publicado en 2011

Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss

artículo científico publicado en 2009

Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.

artículo científico publicado en 2017

HIV Drug Resistance

article

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein ⬇️

artículo científico publicado el 16 de mayo de 2003

Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations

artículo científico publicado en 2003

Kinetics of the establishment of HIV-1 viral interference and comprehensive analysis of the contribution of viral genes

artículo científico publicado en 2015

Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy

scientific article published on 01 January 2006

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type

artículo científico publicado en 2009

Modulation of TRIM5α Activity in Human Cells by Alternatively Spliced TRIM5 Isoforms ⬇️

artículo científico publicado el 1 de junio de 2011

Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles

artículo científico publicado en 2013

Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death.

artículo científico publicado en 2001

Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues

artículo científico publicado en 2005

Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.

scientific article published on April 2004

Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients

artículo científico publicado en 2006

Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial

artículo científico publicado en 2016

Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1.

artículo científico publicado en 2010

Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis

artículo científico publicado en 2002

Lista de obras de

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG.

CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.

Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment

Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α.

Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine

Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in mice

Effect of cell cycle arrest on the activity of nucleoside analogues against human immunodeficiency virus type 1.

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype

Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients

Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity

Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss

Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.

HIV Drug Resistance

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein ⬇️

Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations

Kinetics of the establishment of HIV-1 viral interference and comprehensive analysis of the contribution of viral genes

Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type

Modulation of TRIM5α Activity in Human Cells by Alternatively Spliced TRIM5 Isoforms ⬇️

Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles

Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death.

Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues

Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.

Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients

Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial

Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1.

Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis